B Sangro

Author PubWeight™ 43.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 2012 2.96
2 Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996 2.47
3 Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2010 2.09
4 New therapies for hepatocellular carcinoma. Oncogene 2006 2.05
5 Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001 1.44
6 Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther 2003 1.42
7 Liver transplantation in cirrhotic patients over 60 years of age. Rev Esp Enferm Dig 1998 1.38
8 Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001 1.25
9 Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992 1.10
10 Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant 2013 1.07
11 Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 2001 1.04
12 Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995 1.03
13 Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Ther 2001 0.98
14 Liver changes in patients with hyperthyroidism. Liver 1991 0.94
15 Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis. Eur J Radiol 1992 0.93
16 No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors. Mol Pharm 2012 0.93
17 The promise of gene therapy in gastrointestinal and liver diseases. Gut 2003 0.92
18 Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas. Gene Ther 1999 0.92
19 Ribavirin in desquamative interstitial pneumonia. Chest 1988 0.92
20 Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 1995 0.90
21 [Spontaneous tumor regression. Report of 2 cases]. Med Clin (Barc) 1990 0.89
22 Liver damage using suicide genes. A model for oval cell activation. Am J Pathol 2000 0.88
23 Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl Surg 1998 0.87
24 Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012 0.87
25 Gene therapy of hepatocellular carcinoma. Dig Dis 2001 0.85
26 Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Liver Transpl Surg 1999 0.85
27 Color Doppler-US guidance in transjugular placement of intrahepatic portosystemic shunts. Radiology 1992 0.85
28 Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. Hum Gene Ther 1997 0.84
29 Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut 2002 0.84
30 Prognostic model for early acute rejection after liver transplantation. Liver Transpl 2001 0.83
31 Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis. J Surg Oncol 1988 0.82
32 Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation. Dig Dis Sci 2001 0.82
33 Aortic valve replacement with bioprostheses in liver transplant recipients. J Heart Valve Dis 2000 0.79
34 Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation. Transplantation 1997 0.78
35 Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin. N Engl J Med 1986 0.78
36 Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus. Transplant Proc 2003 0.77
37 Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors. Liver Transpl 2000 0.77
38 Antiemetic combination for PAC (cisplatin-adriamycin-cyclophosphamide) chemotherapy-induced emesis in ovarian cancer. Eur J Gynaecol Oncol 1987 0.77
39 Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease. Haemostasis 1996 0.76
40 Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours. Eur J Nucl Med Mol Imaging 2008 0.75
41 Downstaging to liver resection by radioembolization: a difficult to reach strategy? Author reply. Eur J Surg Oncol 2013 0.75
42 [Fatal pulmonary embolism after embolization of a hepatocellular carcinoma using microspheres]. Radiologia 2008 0.75
43 Renal biopsy with forceps through the femoral vein. J Vasc Interv Radiol 1995 0.75
44 Felty's syndrome: response to cyclosporin A with disappearance of neutrophil autoantibodies. Arthritis Rheum 1991 0.75
45 [Antiemetic inefficacy of high intravenous doses of metoclopramide by short-term infusion in vomiting induced by antineoplastic chemotherapy]. Med Clin (Barc) 1986 0.75
46 Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation. Dig Dis Sci 1998 0.75
47 Subsequent nonmelanoma skin cancer after liver transplantation. Transplant Proc 2012 0.75
48 Increased liver stiffness values in patients with heart failure. Acta Gastroenterol Belg 2013 0.75
49 Gene therapy of primary and metastatic liver tumors. Med Sci Monit 2001 0.75
50 [Treatment of chronic hepatitis B virus infection]. An Sist Sanit Navar 2004 0.75
51 [Gene therapy: what is it and what is its use?]. An Sist Sanit Navar 2005 0.75
52 Transvenous liver biopsy in patients with cirrhosis with use of the femoral venous approach and a flexible forceps. J Vasc Interv Radiol 1994 0.75
53 Effectiveness of aprotinin in orthotopic liver transplantation. Semin Thromb Hemost 1993 0.75
54 [Severe hepatotoxicity caused by amiodarone: description of a case]. Rev Med Univ Navarra 2001 0.75
55 Results of two controlled studies on antiemetic combination against vomiting induced by 5-fluorouracil. Tumori 1987 0.75